M Abe, Y Okubo, H Takahashi, K Endo… - Dermatology and …, 2024 - ncbi.nlm.nih.gov
Methods In PROMINENT, patients received apremilast 30 mg twice daily for 16 weeks in
addition to their existing topical therapy, with the option of topical therapy reduction at the …